n-methylaspartate has been researched along with Tauopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cutler, RG; Furukawa, K; Greig, NH; Jiang, H; Lahiri, DK; Lee, JH; Liu, D; Mattson, MP; Mughal, M; Pitta, M; Ray, B; Villarreal, J | 1 |
1 other study(ies) available for n-methylaspartate and Tauopathies
| Article | Year |
|---|---|
The KATP channel activator diazoxide ameliorates amyloid-β and tau pathologies and improves memory in the 3xTgAD mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Antipsychotic Agents; Calcium; Cells, Cultured; Cerebral Cortex; Diazoxide; Disease Models, Animal; Dose-Response Relationship, Drug; Embryo, Mammalian; Excitatory Amino Acid Agonists; Gene Expression Regulation; Humans; KATP Channels; Membrane Potential, Mitochondrial; Membrane Potentials; Memory Disorders; Mice; Mice, Transgenic; Mutation; N-Methylaspartate; Oxygen; Patch-Clamp Techniques; Potassium Channels, Inwardly Rectifying; Presenilin-1; Rats; RNA, Messenger; tau Proteins; Tauopathies | 2010 |